News | Gastrointestinal system diseases

Opinion

The Pharmaceutical Journal’s most read opinion pieces of 2016

A round up of the most popular opinion pieces of 2016.…

Published: 15 December 2016

Opinion

Most popular features of 2016 from The Pharmaceutical Journal

Dawn Connelly describes the most popular features and infographics published in 2016.…

Published: 15 December 2016

News

Irritable bowel syndrome drug given green light for use in Europe

The European Commission has granted a marketing authorisation to a first-in-class treatment for irritable bowel syndrome (IBS) called eluxadoline (Truberzi) for use in the EU.…

Published: 27 September 2016

News

Legalise cannabis for medical use, MPs say

An influential committee of MPs has called on the government to make cannabis legal for medical use.  The All Party Parliamentary Group (APPG) for Drug Policy Reform wants the drug reclassified from its Schedule 1 — which puts it in the same class as ecstasy and LSD — to Sched…

Published: 15 September 2016

News

Constipation treatment could lengthen cancer survival

Study findings support a role for the mu opioid receptor in cancer progression.…

Published: 14 September 2016

News

Community pharmacy could detect unknown cases of coeliac disease

A proof of concept study has shown how opportunistic testing in community pharmacies may help identify those with coeliac disease who would not otherwise have been tested.…

Published: 2 September 2016

News

Probiotics correct immune function in babies at risk of allergy

In children who received a probiotic at birth, some functional characteristics of regulatory T cells improved, study finds.…

Published: 31 August 2016

News

FDA approves injectable anti-emetic granisetron for chemotherapy patients

The US Food and Drug Administration (FDA) has approved granisetron for the prevention of nausea and vomiting caused by chemotherapy.  The injectable therapy, which is marketed as Sustol by Huron Therapeutics, is an antagonist to the 5-HT3 receptor. Huron Therapeutics says Sustol is …

Published: 12 August 2016

Opinion

Time to halt the overprescribing of proton pump inhibitors

Inappropriate use of proton pump inhibitors can cause a range of side effects and even harm to patients.…

Published: 8 August 2016

Infographic

The development and safety of proton pump inhibitors

Since the discovery of omeprazole in 1979, dispensing of proton pump inhibitors (PPIs) in England has increased more than 100-fold, and several products are now available without prescription. Although PPIs are effective and generally well tolerated, observational studies suggest an association with…

Published: 24 June 2016